Genetic Technologies Ltd
ASX:GTG
Prices of ASX stocks are not being updated. The latest GTG price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genetic Technologies Ltd
ASX:GTG
|
AU |
|
Indo Tambangraya Megah Tbk PT
IDX:ITMG
|
ID |
|
H
|
HEG Ltd
NSE:HEG
|
IN |
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
HK |
|
U
|
Universal Robina Corp
OTC:UVRBF
|
PH |
|
NVR Inc
LSE:0NVR
|
US |
|
P
|
Philip Morris International Inc
XETRA:4I1
|
US |
Intrinsic Value
Is GTG undervalued or overvalued?
See the intrinsic value estimate for Genetic Technologies Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
GTG looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with GTG’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Genetic Technologies Does
Genetic Technologies Ltd is a molecular diagnostics company that develops and sells DNA-based tests, mainly for assessing a person’s inherited risk of disease. Its core products use genetic markers to help doctors and patients understand cancer risk, with a strong focus on breast and colorectal cancer. The company turns laboratory science into tests that can be ordered by healthcare providers and used to guide screening decisions.
- Headquarters
- Australia AU
- Employees
- 55
- IPO date
- Jul 30, 1987
Earnings Waterfall
Genetic Technologies Ltd
The intrinsic value for Genetic Technologies Ltd (GTG) under the Base Case is hidden AUD.
Compared with the last price of 0.039 AUD on Oct 14, the stock appears hidden.